Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.


TSX:CURA - Post by User

Post by blackspade799on Jan 10, 2025 10:20pm
155 Views
Post# 36399087

How DEA disfavored pro-rescheduling parties

How DEA disfavored pro-rescheduling parties

 attorney Shane Pennington, the witnesses’ counsel and a partner at Porter Wright’s Washington, D.C., office who specializes in administrative law, attempts to show in greater detail how the agency “disfavored pro-rescheduling parties, including DEA researchers, doctors, scientists, and the State of Colorado, which has competently regulated a medical marijuana program for over a decade.”

Colorado Gov. Jared Polis requested in a Sept. 30 letter to DEA Administrator Anne Milgram that the state be allowed to present “relevant, unique, and non-duplicative” data that shows “marijuana having medical utility and abuse potential far below opioids.”

In his letter – a copy was attached to Monday’s filing – Polis expressed a fear that any federal rescheduling decision made without considering Colorado’s position “will introduce significant risks” to state-regulated marijuana frameworks, including the ability to regulate sales as well as collect tax revenue.

But, according to Monday’s filing, Milgram “barred Colorado from presenting that data” by ignoring Polis’ letter and declining to extend the state an invitation.

Instead, the DEA mentioned Colorado 27 times in its Jan. 2 filing, part of an effort “to cast doubt on the success of the decade-old state-regulated program,” according to Monday’s claims.

“Yet DEA makes no attempt to engage with the positive evidence from Colorado and summarily rejected Colorado’s request to participate in this hearing,” the filing continued.

“And now, secure in the knowledge that the Administrator’s secret selection process has guaranteed that Colorado will not be able to respond or defend itself, DEA reveals its plan to smear the state’s successful regulatory program in these historic and very public proceedings.”

The DEA also allowed the state of Nebraska, which is attempting to thwart a medical marijuana ballot initiative approved by its voters in November, and the Tennessee Bureau of Investigation to participate in the proceedings.

Both states are opposed to rescheduling, according to their filings.

https://mjbizdaily.com/biased-dea-kept-colorado-out-of-marijuana-rescheduling-hearings-filing-says/

<< Previous
Bullboard Posts
Next >>